AI Summary
✦ ClarthaPrice Forecast
Probabilistic Range
Probabilistic lognormal cone using 1Y realized volatility and analyst-target drift when available.
Revenue Forecast
₹ CrEPS Forecast
₹ / shareMulti-factor synthesis of 5 key dimensions
From 11 analysts
Fundamentals
Fundamentals institutional score is 57 using growth durability 57.1.
Valuation
Valuation institutional score is 68 using relative multiple z-scores where peer dispersion is available.
Analyst Consensus
Analyst View institutional score is 87 using mean target upside 21.2%; dispersion penalty 6.4; recommendation breadth from available consensus.
Technical Structure
Technicals institutional score is 57 using EMA-20 continuation within 5% tolerance; VCP range/volume contraction proxy.
Market Sentiment
Recent news flow is balanced or not decisive enough to tilt the tape. Based on 10 recent ticker-linked news items.
Signal Summary
Market intelligence remains Neutral. valuation and analyst consensus provide support, while market sentiment remain considerations.
Composite weights: Fundamentals 25%, Valuation 20%, Analyst Consensus 20%, Technical Structure 20%, Market Sentiment 15%.
Key Data Points
Important Note: This is market intelligence, not investment advice. Always conduct your own research and consider your financial goals and risk tolerance.
Valuation Metrics
Trading 7.9% below historical median. Valuation is declining — currently in the undervalued zone (z-score: -0.42). Confidence: 83%.
Live forward EPS implies next-12-month EPS of ₹13.96. Applying the stock's normalized valuation corridor produces a fair range of ₹776.46 to ₹992.70, with base value near ₹913.68 (+47.4% vs current price).
Live forward estimate anchored to the company's historical valuation corridor.
Forward EPS
₹13.96
Forward P/E
44.4x
Base Fair Value
₹913.68
Fair Range
₹776.46 - ₹992.70
Upside To Base
+47.4%
Estimate Source
Live forward EPS
Growth Estimate
+0.4%
5Y Average
60.20
Current
60.30
Overvalued
71.11
Undervalued
55.62
5Y Average
39.11
Current
39.17
Overvalued
46.08
Undervalued
31.34
5Y Average
5.05
Current
5.05
Overvalued
5.94
Undervalued
4.04
Peers & Comparison
Sector: Consumer Staples · Theme: FMCG - Foods
| Company | Rev. Growth | Margin | P/E | vs Avg | 52W Perf. |
|---|---|---|---|---|---|
ZYDUS WELLNESS LIMITED ZYDUSWELLFMCG - Foods | +66.9% | 4.1% | 88.3x Premium | +71% vs avg | +32.9% |
HATSUN AGRO PRODUCT LTD. HATSUNFMCG - Foods | +19.3% | 3.4% | 59.3x Premium | +15% vs avg | +5.5% |
VISHAL MEGA MART LIMITED VMMFMCG - Foods | +18.7% | 6.6% | 58.0x Fair | +12% vs avg | -22.4% |
MRS BECTORS FOOD SPE LTD BECTORFOODFMCG - Foods | +16.0% | 7.0% | 50.3x Fair | -3% vs avg | -18.5% |
HINDUSTAN FOODS LIMITED HNDFDSFMCG - Foods | +20.7% | 3.6% | 46.9x Fair | -9% vs avg | +11.2% |
KWALITY WALL'S (INDIA) L KWILFMCG - Foods | +6.3% | -19.5% | — | — | +17.4% |
DODLA DAIRY LIMITED DODLAFMCG - Foods | +19.0% | 5.7% | 25.7x Undervalued | -50% vs avg | -19.5% |
VADILAL INDUSTRIES LTD VADILALINDFMCG - Foods | +57.0% | 10.3% | 33.4x Undervalued | -35% vs avg | +49.6% |
BIKAJI FOODS INTERN LTD trades at a premium (60.2x vs peer avg 51.7x), implying higher growth or quality expectations from the Fmcg - Foods cohort. Peers include ZYDUS WELLNESS LIMITED, HATSUN AGRO PRODUCT LTD., VISHAL MEGA MART LIMITED — selected based on business model, industry classification, market cap similarity, and business theme alignment.
Financials
Real statement data for revenue, earnings quality, conversion, and balance-sheet coverage. Monetary values are shown in Rs crore.
Latest revenue
₹678 CrJun 2026Latest net profit
₹65 CrJun 2026Latest EPS
₹2.58Jun 2026Net margin
15.0%Jun 2026Performance
Bars show revenue and net profit. The line shows net margin.
- Revenue
- Net income
- Net margin %
Earnings
Revenue is shown in crores. EPS is rupees per share.
- Revenue
- EPS
Revenue to profit conversion
Bridge from operating numbers to profit for the latest reported period.
Latest reported period: Jun 2026
Debt level and coverage
Debt, cash and free cash flow compared on the same crore scale.
- Debt
- Free cash flow
- Cash & equivalents
Results
| Metric | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 478 | 598 | 613 | 606 | 565 | 713 | 676 | 585 | 624 | 796 | 731 | 667 | 678 |
| Expenses + | 412 | 509 | 537 | 445 | 472 | 604 | 621 | 506 | 525 | 665 | 636 | 577 | 579 |
| Operating Profit | 66 | 89 | 76 | 161 | 93 | 109 | 56 | 79 | 99 | 130 | 95 | 91 | 99 |
| OPM % | 14% | 15% | 12% | 27% | 16% | 15% | 8% | 13% | 16% | 16% | 13% | 14% | 15% |
| Other Income + | 6 | 6 | 6 | 11 | 7 | 8 | 7 | 7 | 8 | 0 | 10 | 14 | 11 |
| Interest | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 4 | 3 | 2 | 3 |
| Depreciation | 13 | 15 | 15 | 15 | 17 | 17 | 18 | 18 | 18 | 18 | 18 | 19 | 19 |
| Profit before tax | 58 | 78 | 65 | 155 | 80 | 97 | 42 | 65 | 85 | 109 | 84 | 84 | 87 |
| Tax % | 25% | 22% | 24% | 25% | 26% | 26% | 26% | 25% | 26% | 29% | 23% | 24% | 26% |
| Net Profit + | 43 | 61 | 49 | 116 | 60 | 72 | 31 | 48 | 63 | 78 | 65 | 64 | 65 |
| EPS in Rs | 1.73 | 2.45 | 1.96 | 4.64 | 2.38 | 2.88 | 1.23 | 1.93 | 2.52 | 3.10 | 2.58 | 2.54 | 2.58 |
| Raw PDF |
All values in ₹ Crores unless otherwise stated. Source: Screener Master (Standalone).
Events Timeline
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome